A small number of rogue drugs companies are fleecing the NHS out of millions of pounds a year.
They’re exploiting a loophole that allows them to buy up the rights to everyday medicines, hike up the price, and hold our NHS to ransom. It means our cash-strapped health service is forced to spend millions on overpriced drugs rather than spending it on the care our friends and families need.